ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes
INTRODUCTION Associations between amyloid‐tau‐neurodegeneration (ATN) plasma biomarkers and cognition have not been characterized in adults with type 1 diabetes (T1D). METHODS Using data from participants in the Glycemic Variability and Fluctuations in Cognitive Status in Adults with T1D (GluCog) st...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia : diagnosis, assessment & disease monitoring assessment & disease monitoring, 2024-10, Vol.16 (4), p.e70029-n/a |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 4 |
container_start_page | e70029 |
container_title | Alzheimer's & dementia : diagnosis, assessment & disease monitoring |
container_volume | 16 |
creator | Fonseca, Luciana Mascarenhas Beeri, Michal Schnaider Hawks, Zoë W. Jung, Lanee Cleveland, Michael Delgado, Nikki Bulger, Jane Grinspoon, Elizabeth Janess, Kamille Sliwinski, Martin J. Weinstock, Ruth S. Chhatwal, Jasmeer P. Kivisäkk, Pia Germine, Laura Thi Chaytor, Naomi S. |
description | INTRODUCTION
Associations between amyloid‐tau‐neurodegeneration (ATN) plasma biomarkers and cognition have not been characterized in adults with type 1 diabetes (T1D).
METHODS
Using data from participants in the Glycemic Variability and Fluctuations in Cognitive Status in Adults with T1D (GluCog) study (N = 114), we evaluated associations between phosphorylated tau (pTau)181, pTau217, β‐amyloid 42/40 ratio, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) and self‐administered digital cognitive tests, adjusting for age, sex, education, comorbidities (e.g., kidney disease), and glycemic indices.
RESULTS
Higher concentrations of pTau181 and GFAP were associated with slower responses on working memory tasks (pTau181: β = 0.261; p = 0.007; GFAP: β = 0.175, p = 0.036), and higher β‐amyloid 42/40 ratio was associated with better vocabulary (β = 0.260, p = 0.009).
Discussion
Digital cognitive performance was associated with several ATN plasma biomarkers in T1D adults. Prospective studies are needed to understand the utility of these biomarkers in T1D.
Highlights
There is an increase in life expectancy for individuals with type 1 diabetes (T1D).
Few studies investigate the relationship between T1D and neurodegeneration.
We characterize the relation between ATN plasma biomarkers and cognitive function.
Digital cognitive performance was associated with plasma biomarkers in T1D adults. |
doi_str_mv | 10.1002/dad2.70029 |
format | Article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11497176</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_78727beb012346d9b7ea5947398ea2ee</doaj_id><sourcerecordid>3149478370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4049-c7658d9f74e05b5edce3d5d635eca1894c6d0b018af9c9ef1380f7d5a2440fff3</originalsourceid><addsrcrecordid>eNp9kU1rVDEUhoMottRu_AEScCPC1Hze3KxkaP0oFF1Y1yE3ORkz3rkZk0xl_r2Z3lpaF65yyHl4eDkvQi8pOaOEsHfeenam2qSfoGPGJVv0iumnD-YjdFrKmhBChWaCkufoiGshJBf8GH1bXn_Bw5iSx0NMG5t_Qi7YZsAZRlvB45qwj6tY7YhdWk2xxhvAthQoZQNTxXHCdb8FTBtmB6hQXqBnwY4FTu_eE_T944fr88-Lq6-fLs-XVwsniNALpzrZex2UACIHCd4B99J3XIKztNfCdZ4MhPY2aKchUN6ToLy0TAgSQuAn6HL2-mTXZptji783yUZz-5HyythcoxvBqHYINUCzMS46rwcFVmqhuO7BMoDmej-7trthc4gy1WzHR9LHmyn-MKt0Y2i7qqKqa4Y3d4acfu2gVLOJxcE42gnSrhhOGSEd4T1t6Ot_0HXa5andqlGixeq5Io16O1Mup1IyhPs0lJhD9-bQvbntvsGvHua_R_823QA6A7_jCPv_qMzF8oLN0j83ZLgq</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3149478370</pqid></control><display><type>article</type><title>ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes</title><source>Wiley Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Online Library Open Access</source><source>PubMed Central</source><creator>Fonseca, Luciana Mascarenhas ; Beeri, Michal Schnaider ; Hawks, Zoë W. ; Jung, Lanee ; Cleveland, Michael ; Delgado, Nikki ; Bulger, Jane ; Grinspoon, Elizabeth ; Janess, Kamille ; Sliwinski, Martin J. ; Weinstock, Ruth S. ; Chhatwal, Jasmeer P. ; Kivisäkk, Pia ; Germine, Laura Thi ; Chaytor, Naomi S.</creator><creatorcontrib>Fonseca, Luciana Mascarenhas ; Beeri, Michal Schnaider ; Hawks, Zoë W. ; Jung, Lanee ; Cleveland, Michael ; Delgado, Nikki ; Bulger, Jane ; Grinspoon, Elizabeth ; Janess, Kamille ; Sliwinski, Martin J. ; Weinstock, Ruth S. ; Chhatwal, Jasmeer P. ; Kivisäkk, Pia ; Germine, Laura Thi ; Chaytor, Naomi S.</creatorcontrib><description>INTRODUCTION
Associations between amyloid‐tau‐neurodegeneration (ATN) plasma biomarkers and cognition have not been characterized in adults with type 1 diabetes (T1D).
METHODS
Using data from participants in the Glycemic Variability and Fluctuations in Cognitive Status in Adults with T1D (GluCog) study (N = 114), we evaluated associations between phosphorylated tau (pTau)181, pTau217, β‐amyloid 42/40 ratio, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) and self‐administered digital cognitive tests, adjusting for age, sex, education, comorbidities (e.g., kidney disease), and glycemic indices.
RESULTS
Higher concentrations of pTau181 and GFAP were associated with slower responses on working memory tasks (pTau181: β = 0.261; p = 0.007; GFAP: β = 0.175, p = 0.036), and higher β‐amyloid 42/40 ratio was associated with better vocabulary (β = 0.260, p = 0.009).
Discussion
Digital cognitive performance was associated with several ATN plasma biomarkers in T1D adults. Prospective studies are needed to understand the utility of these biomarkers in T1D.
Highlights
There is an increase in life expectancy for individuals with type 1 diabetes (T1D).
Few studies investigate the relationship between T1D and neurodegeneration.
We characterize the relation between ATN plasma biomarkers and cognitive function.
Digital cognitive performance was associated with plasma biomarkers in T1D adults.</description><identifier>ISSN: 2352-8729</identifier><identifier>EISSN: 2352-8729</identifier><identifier>DOI: 10.1002/dad2.70029</identifier><identifier>PMID: 39445343</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Accuracy ; Alzheimer's disease ; Biomarkers ; Cerebrospinal fluid ; cognition ; Cognition & reasoning ; Cognitive ability ; Data collection ; Dementia ; Diabetes ; Endocrinology ; FDA approval ; Glucose ; Kidney diseases ; Life expectancy ; Medical records ; Medical research ; Memory ; Neurodegeneration ; Neuropsychology ; Plasma ; plasma biomarkers ; Risk factors ; Self report ; Statistical analysis ; type 1 diabetes</subject><ispartof>Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2024-10, Vol.16 (4), p.e70029-n/a</ispartof><rights>2024 The Author(s). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4049-c7658d9f74e05b5edce3d5d635eca1894c6d0b018af9c9ef1380f7d5a2440fff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497176/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497176/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,2102,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39445343$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fonseca, Luciana Mascarenhas</creatorcontrib><creatorcontrib>Beeri, Michal Schnaider</creatorcontrib><creatorcontrib>Hawks, Zoë W.</creatorcontrib><creatorcontrib>Jung, Lanee</creatorcontrib><creatorcontrib>Cleveland, Michael</creatorcontrib><creatorcontrib>Delgado, Nikki</creatorcontrib><creatorcontrib>Bulger, Jane</creatorcontrib><creatorcontrib>Grinspoon, Elizabeth</creatorcontrib><creatorcontrib>Janess, Kamille</creatorcontrib><creatorcontrib>Sliwinski, Martin J.</creatorcontrib><creatorcontrib>Weinstock, Ruth S.</creatorcontrib><creatorcontrib>Chhatwal, Jasmeer P.</creatorcontrib><creatorcontrib>Kivisäkk, Pia</creatorcontrib><creatorcontrib>Germine, Laura Thi</creatorcontrib><creatorcontrib>Chaytor, Naomi S.</creatorcontrib><title>ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes</title><title>Alzheimer's & dementia : diagnosis, assessment & disease monitoring</title><addtitle>Alzheimers Dement (Amst)</addtitle><description>INTRODUCTION
Associations between amyloid‐tau‐neurodegeneration (ATN) plasma biomarkers and cognition have not been characterized in adults with type 1 diabetes (T1D).
METHODS
Using data from participants in the Glycemic Variability and Fluctuations in Cognitive Status in Adults with T1D (GluCog) study (N = 114), we evaluated associations between phosphorylated tau (pTau)181, pTau217, β‐amyloid 42/40 ratio, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) and self‐administered digital cognitive tests, adjusting for age, sex, education, comorbidities (e.g., kidney disease), and glycemic indices.
RESULTS
Higher concentrations of pTau181 and GFAP were associated with slower responses on working memory tasks (pTau181: β = 0.261; p = 0.007; GFAP: β = 0.175, p = 0.036), and higher β‐amyloid 42/40 ratio was associated with better vocabulary (β = 0.260, p = 0.009).
Discussion
Digital cognitive performance was associated with several ATN plasma biomarkers in T1D adults. Prospective studies are needed to understand the utility of these biomarkers in T1D.
Highlights
There is an increase in life expectancy for individuals with type 1 diabetes (T1D).
Few studies investigate the relationship between T1D and neurodegeneration.
We characterize the relation between ATN plasma biomarkers and cognitive function.
Digital cognitive performance was associated with plasma biomarkers in T1D adults.</description><subject>Accuracy</subject><subject>Alzheimer's disease</subject><subject>Biomarkers</subject><subject>Cerebrospinal fluid</subject><subject>cognition</subject><subject>Cognition & reasoning</subject><subject>Cognitive ability</subject><subject>Data collection</subject><subject>Dementia</subject><subject>Diabetes</subject><subject>Endocrinology</subject><subject>FDA approval</subject><subject>Glucose</subject><subject>Kidney diseases</subject><subject>Life expectancy</subject><subject>Medical records</subject><subject>Medical research</subject><subject>Memory</subject><subject>Neurodegeneration</subject><subject>Neuropsychology</subject><subject>Plasma</subject><subject>plasma biomarkers</subject><subject>Risk factors</subject><subject>Self report</subject><subject>Statistical analysis</subject><subject>type 1 diabetes</subject><issn>2352-8729</issn><issn>2352-8729</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU1rVDEUhoMottRu_AEScCPC1Hze3KxkaP0oFF1Y1yE3ORkz3rkZk0xl_r2Z3lpaF65yyHl4eDkvQi8pOaOEsHfeenam2qSfoGPGJVv0iumnD-YjdFrKmhBChWaCkufoiGshJBf8GH1bXn_Bw5iSx0NMG5t_Qi7YZsAZRlvB45qwj6tY7YhdWk2xxhvAthQoZQNTxXHCdb8FTBtmB6hQXqBnwY4FTu_eE_T944fr88-Lq6-fLs-XVwsniNALpzrZex2UACIHCd4B99J3XIKztNfCdZ4MhPY2aKchUN6ToLy0TAgSQuAn6HL2-mTXZptji783yUZz-5HyythcoxvBqHYINUCzMS46rwcFVmqhuO7BMoDmej-7trthc4gy1WzHR9LHmyn-MKt0Y2i7qqKqa4Y3d4acfu2gVLOJxcE42gnSrhhOGSEd4T1t6Ot_0HXa5andqlGixeq5Io16O1Mup1IyhPs0lJhD9-bQvbntvsGvHua_R_823QA6A7_jCPv_qMzF8oLN0j83ZLgq</recordid><startdate>202410</startdate><enddate>202410</enddate><creator>Fonseca, Luciana Mascarenhas</creator><creator>Beeri, Michal Schnaider</creator><creator>Hawks, Zoë W.</creator><creator>Jung, Lanee</creator><creator>Cleveland, Michael</creator><creator>Delgado, Nikki</creator><creator>Bulger, Jane</creator><creator>Grinspoon, Elizabeth</creator><creator>Janess, Kamille</creator><creator>Sliwinski, Martin J.</creator><creator>Weinstock, Ruth S.</creator><creator>Chhatwal, Jasmeer P.</creator><creator>Kivisäkk, Pia</creator><creator>Germine, Laura Thi</creator><creator>Chaytor, Naomi S.</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>202410</creationdate><title>ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes</title><author>Fonseca, Luciana Mascarenhas ; Beeri, Michal Schnaider ; Hawks, Zoë W. ; Jung, Lanee ; Cleveland, Michael ; Delgado, Nikki ; Bulger, Jane ; Grinspoon, Elizabeth ; Janess, Kamille ; Sliwinski, Martin J. ; Weinstock, Ruth S. ; Chhatwal, Jasmeer P. ; Kivisäkk, Pia ; Germine, Laura Thi ; Chaytor, Naomi S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4049-c7658d9f74e05b5edce3d5d635eca1894c6d0b018af9c9ef1380f7d5a2440fff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Accuracy</topic><topic>Alzheimer's disease</topic><topic>Biomarkers</topic><topic>Cerebrospinal fluid</topic><topic>cognition</topic><topic>Cognition & reasoning</topic><topic>Cognitive ability</topic><topic>Data collection</topic><topic>Dementia</topic><topic>Diabetes</topic><topic>Endocrinology</topic><topic>FDA approval</topic><topic>Glucose</topic><topic>Kidney diseases</topic><topic>Life expectancy</topic><topic>Medical records</topic><topic>Medical research</topic><topic>Memory</topic><topic>Neurodegeneration</topic><topic>Neuropsychology</topic><topic>Plasma</topic><topic>plasma biomarkers</topic><topic>Risk factors</topic><topic>Self report</topic><topic>Statistical analysis</topic><topic>type 1 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fonseca, Luciana Mascarenhas</creatorcontrib><creatorcontrib>Beeri, Michal Schnaider</creatorcontrib><creatorcontrib>Hawks, Zoë W.</creatorcontrib><creatorcontrib>Jung, Lanee</creatorcontrib><creatorcontrib>Cleveland, Michael</creatorcontrib><creatorcontrib>Delgado, Nikki</creatorcontrib><creatorcontrib>Bulger, Jane</creatorcontrib><creatorcontrib>Grinspoon, Elizabeth</creatorcontrib><creatorcontrib>Janess, Kamille</creatorcontrib><creatorcontrib>Sliwinski, Martin J.</creatorcontrib><creatorcontrib>Weinstock, Ruth S.</creatorcontrib><creatorcontrib>Chhatwal, Jasmeer P.</creatorcontrib><creatorcontrib>Kivisäkk, Pia</creatorcontrib><creatorcontrib>Germine, Laura Thi</creatorcontrib><creatorcontrib>Chaytor, Naomi S.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Alzheimer's & dementia : diagnosis, assessment & disease monitoring</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fonseca, Luciana Mascarenhas</au><au>Beeri, Michal Schnaider</au><au>Hawks, Zoë W.</au><au>Jung, Lanee</au><au>Cleveland, Michael</au><au>Delgado, Nikki</au><au>Bulger, Jane</au><au>Grinspoon, Elizabeth</au><au>Janess, Kamille</au><au>Sliwinski, Martin J.</au><au>Weinstock, Ruth S.</au><au>Chhatwal, Jasmeer P.</au><au>Kivisäkk, Pia</au><au>Germine, Laura Thi</au><au>Chaytor, Naomi S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes</atitle><jtitle>Alzheimer's & dementia : diagnosis, assessment & disease monitoring</jtitle><addtitle>Alzheimers Dement (Amst)</addtitle><date>2024-10</date><risdate>2024</risdate><volume>16</volume><issue>4</issue><spage>e70029</spage><epage>n/a</epage><pages>e70029-n/a</pages><issn>2352-8729</issn><eissn>2352-8729</eissn><abstract>INTRODUCTION
Associations between amyloid‐tau‐neurodegeneration (ATN) plasma biomarkers and cognition have not been characterized in adults with type 1 diabetes (T1D).
METHODS
Using data from participants in the Glycemic Variability and Fluctuations in Cognitive Status in Adults with T1D (GluCog) study (N = 114), we evaluated associations between phosphorylated tau (pTau)181, pTau217, β‐amyloid 42/40 ratio, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) and self‐administered digital cognitive tests, adjusting for age, sex, education, comorbidities (e.g., kidney disease), and glycemic indices.
RESULTS
Higher concentrations of pTau181 and GFAP were associated with slower responses on working memory tasks (pTau181: β = 0.261; p = 0.007; GFAP: β = 0.175, p = 0.036), and higher β‐amyloid 42/40 ratio was associated with better vocabulary (β = 0.260, p = 0.009).
Discussion
Digital cognitive performance was associated with several ATN plasma biomarkers in T1D adults. Prospective studies are needed to understand the utility of these biomarkers in T1D.
Highlights
There is an increase in life expectancy for individuals with type 1 diabetes (T1D).
Few studies investigate the relationship between T1D and neurodegeneration.
We characterize the relation between ATN plasma biomarkers and cognitive function.
Digital cognitive performance was associated with plasma biomarkers in T1D adults.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>39445343</pmid><doi>10.1002/dad2.70029</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2352-8729 |
ispartof | Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2024-10, Vol.16 (4), p.e70029-n/a |
issn | 2352-8729 2352-8729 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11497176 |
source | Wiley Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Online Library Open Access; PubMed Central |
subjects | Accuracy Alzheimer's disease Biomarkers Cerebrospinal fluid cognition Cognition & reasoning Cognitive ability Data collection Dementia Diabetes Endocrinology FDA approval Glucose Kidney diseases Life expectancy Medical records Medical research Memory Neurodegeneration Neuropsychology Plasma plasma biomarkers Risk factors Self report Statistical analysis type 1 diabetes |
title | ATN blood biomarkers are related to digital cognitive assessment in type 1 diabetes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A29%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ATN%20blood%20biomarkers%20are%20related%20to%20digital%20cognitive%20assessment%20in%20type%201%20diabetes&rft.jtitle=Alzheimer's%20&%20dementia%20:%20diagnosis,%20assessment%20&%20disease%20monitoring&rft.au=Fonseca,%20Luciana%20Mascarenhas&rft.date=2024-10&rft.volume=16&rft.issue=4&rft.spage=e70029&rft.epage=n/a&rft.pages=e70029-n/a&rft.issn=2352-8729&rft.eissn=2352-8729&rft_id=info:doi/10.1002/dad2.70029&rft_dat=%3Cproquest_doaj_%3E3149478370%3C/proquest_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3149478370&rft_id=info:pmid/39445343&rft_doaj_id=oai_doaj_org_article_78727beb012346d9b7ea5947398ea2ee&rfr_iscdi=true |